Bonny Deal: Wyeth Acquires Scottish Drug Discovery Firm Haptogen
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm hopes to use Haptogen’s technology to generate novel protein therapeutics that can be made orally bioavailable, VP-Biologic Technologies Projan tells “The Pink Sheet” DAILY.